Triple

T22690336
Position Surface form Disambiguated ID Type / Status
Subject IL-17A E561033 entity
Predicate alternativeName P39 FINISHED
Object CTLA-8 — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CTLA-8 | Statement: [IL-17A, alternativeName, CTLA-8]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: CTLA-8
Context triple: [IL-17A, alternativeName, CTLA-8]
  • A. B7-H1
    B7-H1, also known as PD-L1, is an immune checkpoint protein expressed on various cells that modulates T-cell activity and is targeted by certain cancer immunotherapies.
  • B. CD3 complex
    The CD3 complex is a multi-subunit protein complex associated with the T-cell receptor that is essential for T-cell activation and signal transduction in the immune system.
  • C. CD22
    CD22 is a B-cell–specific surface glycoprotein that functions as an inhibitory co-receptor modulating B cell receptor signaling and immune responses.
  • D. IL-64
    IL-64 is a major east–west state highway in Illinois that runs from the Mississippi River through the Chicago metropolitan area.
  • E. programmed cell death protein 1
    Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor on T cells that downregulates immune responses and promotes self-tolerance, making it a key target in cancer immunotherapy.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: CTLA-8
Target entity description: CTLA-8 is an early designation for interleukin-17A (IL-17A), a pro-inflammatory cytokine produced mainly by Th17 cells that plays a key role in immune responses and inflammatory diseases.
  • A. B7-H1
    B7-H1, also known as PD-L1, is an immune checkpoint protein expressed on various cells that modulates T-cell activity and is targeted by certain cancer immunotherapies.
  • B. CD3 complex
    The CD3 complex is a multi-subunit protein complex associated with the T-cell receptor that is essential for T-cell activation and signal transduction in the immune system.
  • C. CD22
    CD22 is a B-cell–specific surface glycoprotein that functions as an inhibitory co-receptor modulating B cell receptor signaling and immune responses.
  • D. IL-64
    IL-64 is a major east–west state highway in Illinois that runs from the Mississippi River through the Chicago metropolitan area.
  • E. programmed cell death protein 1
    Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor on T cells that downregulates immune responses and promotes self-tolerance, making it a key target in cancer immunotherapy.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454d71b48190a1f80af9f82b6fcf completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1789a1fd08190bce5fa0babe695d3 completed April 29, 2026, 3:18 a.m.
Created at: April 17, 2026, 3:13 p.m.